The "zukunft.niedersachsen" funding programme is contributing two million euros to the project. < During a bile duct endoscopy: Prof. Benjamin Heidrich and Dr. Friederike Klein perform the examinati .

PLT012 received FDA fast track status for liver cancer, with an ongoing trial evaluating safety and early activity of the CD36-targeting immunotherapy.

Inflammatory Bowel Disease (IBD) is a long-term condition that causes ulcers and swelling in the digestive tract.

The gallbladder plays a quiet but critical role in digestion, and when this organ malfunctions, it sends specific distress signals that require attention.

‘I thought I had endometriosis – then I got my stage 4 cancer diagnosis’ - Tamara Mulley was diagnosed with stage 4 cholangiocarcinoma, or bile duct cancer, and told that she had ‘two years to live’ ...

Louise Wallace is calling for greater awareness of cholangiocarcinoma, which has symptoms that can easily be dismissed as ...

K-State Beef Cattle Institute experts say liver flukes can pose serious health risks to cattle, making proactive disease management essential.

Zenocutuzumab--zbco, marketed as BIZENGRI (R), received Breakthrough Therapy Designation from the FDA in October 2025 and was granted accelerated approval in December 2024 for adults with advanced ...

Primary biliary cholangitis (PBC) is a chronic cholestatic disorder in which symptoms exert a direct influence on patients’ quality of life. Beyond pruritus and fatigue, patients with PBC are also ...

FDA orphan designation for zenocutuzumab‑zbco targets NRG1 fusion–positive advanced cholangiocarcinoma, a small molecular subset within an aggressive malignancy with <15% five-year survival. Orphan ...

Mirum Pharma receives Health Canada authorization for maralixibat to treat cholestatic pruritus in patients with Alagille syndrome: Toronto Saturday, February 7, 2026, 15:00 Hrs [ ...

Lucknow has welcomed a significant addition to its healthcare landscape with the formal inauguration of Dr Cancer, a ...